Attention-deficit hyperactivity disorder (ADHD) is often underdiagnosed in women and girls (Attoe and Climie, 2023). Misdiagnosis and underdiagnosis of ADHD in women can have lasting impacts on social emotional wellbeing, feelings of control, and the ability to form and maintain relationships (Agnew-Blais, 2024; Skoglund et al., 2023). There are a number of challenges associated with diagnosing ADHD in women, including lower likelihood of diagnosis in childhood, past misdiagnoses, gender roles, changes in hormonal life stages and more (Babinski and Libsack, 2025, Osianlis, et al., 2026). Integrated healthcare providers are uniquely positioned to address earlier and more accurate ADHD diagnosis rates for women and girls. This presentation will explore up-to-date research on the key differences in the lived experience of women diagnosed with ADHD and how awareness of these experiences is critical to improving care. We will discuss how screening and assessing for ADHD in integrated healthcare settings can help with the ultimate goal of increasing accuracy and timeliness of ADHD diagnoses in women. We will also provide case examples showcasing common examples of screening for ADHD in integrated healthcare settings.